Rob Dillard

Urban Health Today

<p>The overwhelming majority of Alzheimer&#8217;s disease clinical trials are composed of White individuals. In part 4 of a 7-part panel discussion, Drs. Monique Nugent, Eric Griggs, and Barry Greenberg discuss the deleterious impact of a lack of representation on treating Alzheimer&#8217;s. As noted by Dr. Greenberg, to understand Alzheimer&#8217;s disease, it is imperative to understand it in all people.</p>


Tamara Thomas

Pediatric Sickle Cell Complications Spike in Colder Climates, New Study Finds

Sickle Cell Disease

Health Disparities in Alzheimer’s Trials, Treatments

Video Insights

The Importance of Early Diagnosis in Alzheimer's Disease

Latest News

A group of panelists discuss the deleterious impact of a lack of representation on treating Alzheimer's.

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Gastroenterology

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Digital Health

Dermatology

Pulmonology

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe